Association between TGFBR1*6A and osteosarcoma: A Chinese case-control study
Open Access
- 29 April 2010
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 169
Abstract
Background: TGFBR1*6A is a common hypomorphic variant of transforming growth factor β receptor 1 (TGFBR1). TGFBR1*6A is associated with an increased cancer risk, but the association of this polymorphism with osteosarcoma remains unknown. We have measured the frequency of TGFBR1*6A variants in osteosarcoma cases and controls. Methods: Our case-control study is based on 168 osteosarcoma patients and 168 age- and gender-matched controls. Blood samples were obtained and the TGFBR1*6A variant determined by PCR amplification and DNA sequencing. The odds ratio (OR) and 95% confidence interval (95% CI) for the TGFBR1*6A polymorphism were calculated by unconditional logistic regression, adjusted for both age and gender. Three models - dominant, additive and recessive - were used to analyze the contribution of the TGFBR1*6A variant to osteosarcoma susceptibility. Results: Heterozygotic and homozygotic TGFBR1*6A variants represented 50.4% and 6.0% of the 168 cases, whereas the controls had 18. 5% and 1.3%, respectively. ORs for homozygosity and heterozygosity of the TGFBR1*6A allele were 4.6 [95% CI, 2.33-7.97] and 2.9 [95% CI, 1.59-5.34] in the additive model. There were significant increases in the TGFBR1*6A variants in osteosarcoma cases compared to control in all 3 models. Further analysis showed that TGFBR1*6A genotypes were not associated with gender, age, or tumor location. However, TGFBR1*6A was significantly associated with less metastasis. Conclusions: TGFBR1*6A, a dominant polymorphism of TGFBR1, is associated with increased susceptibility and metastasis spread of osteosarcoma.Keywords
This publication has 39 references indexed in Scilit:
- The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control studyBMC Cancer, 2009
- Tgfbr1Haploinsufficiency Is a Potent Modifier of Colorectal Cancer DevelopmentCancer Research, 2009
- TGFβ in CancerCell, 2008
- TGFBR1*6A Enhances the Migration and Invasion of MCF-7 Breast Cancer Cells through RhoA ActivationCancer Research, 2008
- TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health StudyBMC Cancer, 2007
- TGFBR1*6A and Int7G24A variants of transforming growth factor-β receptor 1 in Swedish familial and sporadic breast cancerBritish Journal of Cancer, 2007
- New Insights into Breast Cancer Genetics and Impact on Patient ManagementCurrent Treatment Options in Oncology, 2007
- Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expressionGenes & Development, 2006
- Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinomaGenes & Development, 2006
- Differential inhibitory effects of TGF‐β on EGF‐, PDGF‐, and HBGF‐1‐stimulated MG63 human osteosarcoma cell growth: Possible involvement of growth factor interactions at the receptor and postreceptor levelsJournal of Cellular Physiology, 1989